AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing ...

PR Newswire (press release)

Long-term use of orally inhaled corticosteroids, such as budesonide , a component of symbicort, may affect normal bone metabolism resulting in a loss of bone ...



and more »

Salix Pharmaceuticals Reports 4Q2009 and FY2009 Results

MarketWatch (press release)

"The development of crofelemer and budesonide foam progressed during 2009. In August, we completed the dose selection stage (Stage 1) of the ADVENT trial, ...

Salix Pharmaceuticals Reports 4Q2009 and FY2009 Results istockAnalyst.com (press release)



all 45 news articles »

AAAI: COPD Patients Respond to Formoterol

MedPage Today

Some 222 patients received twice-daily budesonide /formoterol pressurized metered- dose inhaler 320/9 g, while the same number received the same drugs in a ...



and more »